echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Data: analysis of six characteristics of drug retail market in 2015

    Data: analysis of six characteristics of drug retail market in 2015

    • Last Update: 2016-01-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: network 2016-01-26 2015 is a key year for China to continue to deepen reform in various fields, and the pharmaceutical retail industry is embracing the market with practical actions In this year, Yifeng and ordinary people became chain drugstores landing in A-share after Yixintang, and then three enterprises competed to launch merger and acquisition The first two are connected to several cities in the existing key markets to consolidate their respective market positions In June, Yixintang purchased 165 pharmacies in Shanxi Province While strengthening the market positions of Southwest China and Shanxi Province, it entered Shanghai, Tianjin, Hainan and other markets through various capital means, such as the establishment of merger and acquisition funds, non-public issuance of shares to specific objects, etc., and headed for CVS China And strive to move forward In this year, thanks to large-scale M & A, especially the integration of Fumei Yixing pharmacy and Jinxiang pharmacy, the sales volume in the first half of the year increased by 46.6% year on year In 2015, the chain drugstores in Dalian transformed and upgraded, and continuously cultivated the market Shandong market is full of gunpowder and has distinct regional chain characteristics Unlike Shandong market, which is characterized by "one group, one group", Zhejiang chain drugstores tend to be mature and stable, seeking diversified development Shenzhen retail market flows in a state of "saturation", and Dalian chains are constantly seeking ways to break through The competition and skills of all players have jointly influenced the change of the sales situation of the whole drug retail market Based on the monitoring data from the data center of CFDA Southern Institute of pharmaceutical economics, this paper makes a simple analysis of the drug retail market in the first three quarters of 2015 1 In the first half of 2015, the price of traditional Chinese medicine kept falling after rising in recent years The industry of traditional Chinese medicine is facing a "cold winter" However, the cooling of raw material market did not allow the retail terminal to enjoy many preferential policies, high inventory and delayed price fluctuations and other reasons make the price of traditional Chinese medicine still high in the retail market Not long ago, the general office of the State Council forwarded the plan for the protection and development of traditional Chinese medicine (2015-2020) formulated by the Ministry of industry and information technology, the State Administration of traditional Chinese medicine and other departments, and made a comprehensive plan for the future resource protection and industrial development of traditional Chinese Medicine in China This is the first national plan on the protection and development of traditional Chinese medicine in China, especially the proposal of "establishing the price formation mechanism of traditional Chinese medicine reflecting the production and operation costs, market supply and demand and resource scarcity" In the first three quarters of 2015, the sales volume of traditional Chinese medicine in the retail market increased slightly, but the market share decreased by 1 percentage point 2 The sales volume of medical equipment in physical stores was impacted In 2015, the State Food and Drug Administration released 90 industrial standards for medical equipment, further improved the medical equipment standard system in China, improved the quality of medical equipment products, and promoted the healthy development of the medical equipment industry As far as retail terminal sales are concerned, the impact of online drugstores on physical stores is most affected by medical devices According to statistics, the top products of online drugstores are mainly family planning products, contact lenses, sphygmomanometers, blood glucose meters, etc The blowout of medical devices including condoms and other family planning products on the Internet has led to a decline in the sales volume of physical stores The sales market share in the first three quarters of 2015 decreased by 0.2 percentage points compared with the first three quarters of 2014, and there is still a downward trend in the future 3 In recent years, with the rapid development of China's big health industry, the concept of big health has gradually become popular At the same time, with the aging of the population and the adjustment of the national policy on "two children in an all-round way", great health needs will be brought, thus promoting the vigorous development of the whole medical and pharmaceutical health industry It is expected to reach the 12th Five Year Plan At the end, the scale of health industry will be close to 3 trillion, ranking first in the world The huge market has attracted many pharmaceutical enterprises to join the competition and try to get a share Taiji Group's Taiji water of 11.99 yuan, monkey mushroom biscuits in the river, Yimeng and jinliwang health drinks of Yiling pharmaceutical were born These are the embodiment of cross-border drug industry into the field of health In the retail market, many large chains are also layout, competing for the cake in the field of big health In the first three quarters of 2015, the total sales volume of health care products accounted for 8.79% of the market share of the whole retail market, up 0.49% year on year Compared with 2014, the top ten ranking categories and positions in 2015 are the same (see Table 1), among which the ones with large market share changes include vitamin supplement, microelement, protein, etc., improvement of growth and development, increase of bone mineral density, up 0.86 percentage points In addition, the market share of chronic health care drugs for lowering blood glucose, blood lipid and blood pressure also increased by 0.51 percentage points, while the market share of beauty care and immune regulation decreased by 0.64 and 0.48 percentage points respectively 4 The market share of Chinese patent medicine continued to rise On the contrary, the total sales volume of chemical medicine in the first three quarters of 2015 accounted for 28.82% of the market share of the whole retail market, which continued to rise, 1.12 percentage points higher than that in the first three quarters of 2014 The top ten ranking categories are the same (see Table 2), and only gynecological drugs and antipyretic and antidote drugs exchange ranking position Among the top ten, only tonic and orthopedic medicine increased, with market share rising by 1.70% and 0.55% year-on-year respectively, especially tonic and health care, which is closely related to the public's concept of health promotion In contrast, the market share of chemical drugs slightly shrank, with the total sales volume in the first three quarters of 2015 accounting for 42.28% of the market share, down 0.62% year on year Compared with 2014, the top 10 categories remain unchanged (see Table 3), and the blood and hematopoietic system drugs in the ranking order have increased by 1.05% from ninth to seventh The market share of anti-tumor drugs, immunomodulators and circulatory drugs increased by 1.44 and 1.13 percentage points respectively However, the share of digestive system, metabolic drugs, genitourinary system and sex hormones decreased by 2.41% and 0.50% respectively In addition, systemic anti infective drugs also decreased by 0.32%, which is closely related to "the most severe anti infective order in history" and the notice on the guiding principles of clinical application of antimicrobial drugs (2015 version) and the notice on Further Strengthening the management of clinical application of antimicrobial drugs issued by the National Health and Family Planning Commission 5 The top ten ranking tends to be stable in the first three quarters of 2015 The top ten ranking of six categories in the retail market is shown in the table Generally speaking, there is little difference between 2014 and 2015 in the top ten drugs, and the ranking position is slightly different The increase of work pressure, the change of diet and life and other factors are leading to the increase of gastrointestinal problems, and the sales volume of gastrointestinal medicine market is also rising, but the competition of products is slightly stable Compared with 2014, only Jianwei Xiaoshi tablet and esomeprazole magnesium enteric coated tablet swap the ranking position in the top ten rankings in 2015 (see Table 4), compared with 2014 The annual market share is relatively small, ranging from - 0.17% to 0.24% In 2014 and 2015, cardiovascular and cerebrovascular drugs ranked in the top three places firmly, while the last seven places changed a lot (see Table 5), but in general, the market share of other products except ginkgo leaves did not change much year on year On May 20, 2015, CFDA issued the notice on the illegal production and sales of Ginkgo biloba drugs by Guilin Xingda Pharmaceutical Co., Ltd and the notice on the special treatment of Ginkgo biloba drugs Subsequently, the special treatment of Ginkgo biloba extracts and preparations was rapidly carried out in the whole country, including many well-known pharmaceutical enterprises Ginkgo biloba preparation was recalled rapidly, and drugstores took off products one after another The sales volume of Ginkgo biloba preparation immediately fell In the first three quarters of 2015, it was 1.86% lower than that in the first three quarters of 2014, of which the sales volume in the first half of 2015 was stable, mainly due to the gradual recovery from the decline in late May to July Compared with 2014, the top ten ranking of cold drugs changed a lot in 2015 (see Table 6), there was no specific advantage brand, and the market share did not open a big gap The market share of paracetamol cold medicine declined slightly in 2014, and returned in 2015 Traditional Chinese patent medicine is more and more occupying the market, and the sales volume is growing There is a big difference in the ranking of antihypertensive drugs in two years (see Table 7) Amlodipine besylate alone has been ranked first in the list, accounting for more than 15% of the market share in two years, with obvious advantages The top ten are all chemical drugs, none of which is on the list In the past two years, the six ranking of vitamins are the same (see Table 8), and the market share is stable Brand medicine has obvious advantages and is favored by the majority of consumers At the same time, the health care products of vitamins have outstanding performance in the market in recent years The liberalization of the two-child policy will definitely promote the future retail of health care products such as vitamins and minerals, especially children's vitamins In the retail market of throat medicine, Chinese patent medicine accounts for the vast majority, and 9 of the top 10 are Chinese patent medicine (see Table 9) Generally speaking, the market share of each product is similar and has its own advantages Compared with 2014, Yanyan tablet is relatively stable in the market, accounting for more than 6% in the first three quarters of two years, while Lanqin oral liquid increased by 2.05% year-on-year, ranking the first, with great potential 6 "Internet +" drives the development of medical e-commerce "Internet + medicine" as a major trend in the future In recent years, Baidu, Alibaba and Tencent have deployed Internet medicine, Ali health, tmall medical center, Jingdong medical city, etc have driven the development of medical e-commerce, and various chains have started to "touch the Internet" As of October 7, 2015, 460 enterprises have obtained the qualification certificate of Internet drug trading service approved by CFDA, and there are 342 online pharmacies that can directly sell drugs to consumers At present, the operation of offline pharmacies is under more and more serious impact The State Council cancels the qualification examination of designated pharmacies for basic medical insurance and the qualification examination of medical institutions for basic medical insurance, which is good for pharmacies In the future, offline drugstores will not only rely on high cost performance, but also pre-sale and after-sale services to win consumers To do well in offline personalized services may be a magic weapon for drugstores to compete with pharmaceutical e-commerce 2015 is the closing year of the 12th Five Year Plan In May 2011, the Ministry of Commerce issued the 12th Five Year Plan Outline for drug distribution industry, which put forward specific goals for drug retail industry: "the annual sales of the top 100 chain stores account for more than 60% of the total sales of drug retail enterprises; the proportion of chain drugstores in all zero sales stores has increased to more than 2 / 3", but by 2014 At the end of the year, the former one achieved less than 45%, the latter less than 40%, only 39.42%, so far it is difficult to meet the requirements of the outline In 2016, China's drug retail market will also develop in the direction of rapid scale and intensification.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.